| MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma (NCT01748721) | Morphotek | 2013-11-01 |
| Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer (NCT01987596) | Barbara Ann Karmanos Cancer Institute | 2013-08-01 |
| Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery (NCT01791088) | University of Chicago | 2012-06-13 |
| Positron Emission Tomography/Magnetic Resonance Imaging in Patients (NCT01557881) | Case Comprehensive Cancer Center | 2012-02-01 |
| Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy (NCT01346267) | University of South Florida | 2011-05-01 |
| Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma (NCT01273090) | Children's Oncology Group | 2011-05-01 |
| Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant (NCT01305200) | Children's Oncology Group | 2011-03-01 |
| MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia (NCT01231919) | National Cancer Institute (NCI) | 2011-01-01 |
| Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors (NCT01240538) | National Cancer Institute (NCI) | 2010-12-01 |
| INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease (NCT01164163) | Children's Oncology Group | 2010-09-01 |
| Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors (NCT01141244) | National Cancer Institute (NCI) | 2010-06-01 |
| Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (NCT01126346) | Wake Forest University Health Sciences | 2010-05-01 |
| Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer (NCT01053494) | Wake Forest University Health Sciences | 2010-04-01 |
| Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia (NCT01088763) | National Cancer Institute (NCI) | 2010-03-01 |
| Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma (NCT01204450) | UNC Lineberger Comprehensive Cancer Center | 2009-11-01 |
| AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors (NCT00985868) | Cancer Research UK | 2009-09-01 |
| Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer (NCT00949117) | University of South Florida | 2009-09-01 |
| Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma (NCT00994500) | National Cancer Institute (NCI) | 2009-08-01 |
| Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia (NCT00933985) | National Cancer Institute (NCI) | 2009-06-01 |
| Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment (NCT00929903) | National Cancer Institute (NCI) | 2009-06-01 |
| Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment (NCT00880282) | National Cancer Institute (NCI) | 2009-04-01 |
| Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors (NCT00788125) | City of Hope Medical Center | 2008-09-03 |
| Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial (NCT00890435) | Children's Oncology Group | 2008-07-01 |
| Education Intervention in Encouraging Health Providers to Talk With Cancer Patients About the Use of Complementary and Alternative Medicine (NCT00608933) | M.D. Anderson Cancer Center | 2008-06-01 |
| Aflibercept in Treating Young Patients With Relapsed or Refractory Solid Tumors (NCT00622414) | National Cancer Institute (NCI) | 2008-04-01 |
| Evaluating Dactinomycin and Vincristine in Young Patients With Cancer (NCT00674193) | Children's Oncology Group | 2008-02-01 |
| IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor (NCT00609141) | National Cancer Institute (NCI) | 2008-01-01 |
| Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy (NCT00429702) | University of South Florida | 2007-10-01 |
| Effect of Bevacizumab and VEGF on Platelet Clustering in Patients Who Are Receiving Bevacizumab for Cancer (NCT00898794) | Kantonsspital Graubuenden | 2007-10-01 |
| CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide (NCT00514345) | Children's Cancer and Leukaemia Group | 2007-07-01 |
| Cancer Occurrence and Outcome in Young Patients Undergoing Cancer Treatment at the Vanderbilt-Ingram Cancer Center (NCT00670605) | Vanderbilt University | 2007-06-01 |
| Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin (NCT00458887) | Children's Oncology Group | 2007-05-01 |
| Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma (NCT00458731) | National Cancer Institute (NCI) | 2007-05-01 |
| High-Dose Methotrexate in Treating Young Patients With Solid Tumors (NCT00513981) | Children's Cancer and Leukaemia Group | 2007-03-01 |
| Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor (NCT00638898) | City of Hope Medical Center | 2007-02-26 |
| Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment (NCT00458744) | Children's Oncology Group | 2007-02-01 |
| Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer (NCT00897871) | Children's Cancer and Leukaemia Group | 2007-02-01 |
| Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer (NCT00112996) | M.D. Anderson Cancer Center | 2007-01-01 |
| Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia (NCT00886496) | Enzon Pharmaceuticals, Inc. | 2006-11-01 |
| Sunitinib in Treating Young Patients With Refractory Solid Tumors (NCT00387920) | National Cancer Institute (NCI) | 2006-10-01 |
| Telephone-Based Cancer Education With or Without Telephone-Based Counseling in Young Participants (NCT00459238) | Georgetown University | 2006-10-01 |
| High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors (NCT00536601) | Roswell Park Cancer Institute | 2006-06-29 |
| Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma (NCT00363272) | National Cancer Institute (NCI) | 2006-06-01 |
| Pharmacokinetics of Dactinomycin in Young Patients With Cancer (NCT00900354) | Children's Cancer and Leukaemia Group | 2006-06-01 |
| Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer (NCT00899808) | Rutgers, The State University of New Jersey | 2006-05-01 |
| Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors (NCT00303940) | National Institutes of Health Clinical Center (CC) | 2005-12-01 |
| Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors (NCT00138216) | Children's Oncology Group | 2005-10-01 |
| Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors (NCT00281944) | National Cancer Institute (NCI) | 2005-09-01 |
| PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma (NCT00253474) | National Institutes of Health Clinical Center (CC) | 2005-09-01 |
| Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy (NCT00258180) | Johns Hopkins University | 2005-08-15 |
| Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia (NCT00217412) | National Cancer Institute (NCI) | 2005-08-01 |
| Tissue Sample Collection From Patients With Fanconi Anemia (NCT00899522) | OHSU Knight Cancer Institute | 2005-08-01 |
| Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors (NCT00112619) | Pediatric Brain Tumor Consortium | 2005-08-01 |
| Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer (NCT00349024) | Children's Cancer and Leukaemia Group | 2005-07-01 |
| Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy (NCT00296049) | Wake Forest University Health Sciences | 2005-07-01 |
| Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors (NCT00107458) | Children's Oncology Group | 2005-05-01 |
| Acupressure in Preventing Nausea and Vomiting in Young Cancer Patients Receiving Chemotherapy (NCT00310063) | Wake Forest University Health Sciences | 2005-04-01 |
| Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors (NCT00112645) | Milton S. Hershey Medical Center | 2005-04-01 |
| Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas (NCT00101270) | National Cancer Institute (NCI) | 2005-03-01 |
| Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes (NCT00104962) | National Cancer Institute (NCI) | 2005-03-01 |
| Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer (NCT00357500) | Dana-Farber Cancer Institute | 2005-01-01 |
| Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma (NCT00101205) | National Cancer Institute (NCI) | 2004-11-01 |
| Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors (NCT00436761) | Milton S. Hershey Medical Center | 2004-05-01 |
| Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors (NCT00900471) | Wake Forest University Health Sciences | 2004-04-01 |
| 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia (NCT00079404) | National Cancer Institute (NCI) | 2004-03-01 |
| Collecting and Storing Blood Samples From Patients With Cancer (NCT00900120) | University of Medicine and Dentistry of New Jersey | 2004-03-01 |
| Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer (NCT00402935) | Case Comprehensive Cancer Center | 2004-02-01 |
| Bevacizumab in Treating Young Patients With Refractory Solid Tumors (NCT00085111) | National Cancer Institute (NCI) | 2003-12-01 |
| Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma (NCT00075634) | National Cancer Institute (NCI) | 2003-12-01 |
| Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors (NCT00070473) | Children's Oncology Group | 2003-10-01 |
| Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases (NCT00084695) | Milton S. Hershey Medical Center | 2003-09-01 |
| Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression (NCT00069927) | University of South Florida | 2003-08-01 |
| Anidulafungin in Treating Immunocompromised Children With Neutropenia (NCT00068471) | National Cancer Institute (NCI) | 2003-07-01 |
| Study of @neWorld: A Virtual Community for Children With Cancer (NCT00070421) | Leap of Faith Technologies | 2003-04-01 |
| Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors (NCT00389584) | University of California, Davis | 2002-12-01 |
| Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors (NCT00039481) | National Cancer Institute (NCI) | 2002-11-01 |
| FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia (NCT00053963) | National Cancer Institute (NCI) | 2002-09-01 |
| Gefitinib in Treating Children With Refractory Solid Tumors (NCT00040781) | National Cancer Institute (NCI) | 2002-06-01 |
| ABT-751 in Treating Young Patients With Refractory Solid Tumors (NCT00036959) | National Institutes of Health Clinical Center (CC) | 2002-03-01 |
| Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors (NCT00049023) | O'Dorisio, M S | 2002-01-01 |
| Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy (NCT00030108) | National Institutes of Health Clinical Center (CC) | 2001-11-01 |
| Bortezomib in Treating Children With Advanced Solid Tumors (NCT00021216) | National Cancer Institute (NCI) | 2001-11-01 |
| Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors (NCT00003750) | Children's Oncology Group | 2001-10-01 |
| Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma (NCT00027937) | Fred Hutchinson Cancer Center | 2001-08-01 |
| Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors (NCT00024284) | Bristol-Myers Squibb | 2001-06-01 |
| Registration and Informed Consent Study for the Childhood Cancer Research Network (NCT00433394) | Children's Oncology Group | 2001-05-01 |
| Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas (NCT00012181) | National Cancer Institute (NCI) | 2001-04-01 |
| Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment (NCT00006348) | Alliance for Clinical Trials in Oncology | 2000-10-01 |
| Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants (NCT00008424) | Children's Oncology Group | 2000-10-01 |
| Ecteinascidin 743 in Treating Children With Refractory Solid Tumors (NCT00006463) | Children's Oncology Group | 2000-10-01 |
| Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer (NCT00003070) | Children's Oncology Group | 2000-09-01 |
| Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy (NCT00006095) | Children's Oncology Group | 2000-07-01 |
| Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma (NCT00006102) | National Cancer Institute (NCI) | 2000-07-01 |
| Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors (NCT00020150) | National Cancer Institute (NCI) | 2000-06-01 |
| Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment (NCT00005811) | National Cancer Institute (NCI) | 2000-04-01 |
| Quality of Life in Children Treated for Cancer (NCT00005881) | Children's Oncology Group | 2000-04-01 |
| BMS-214662 in Treating Patients With Solid Tumors (NCT00005973) | National Cancer Institute (NCI) | 2000-04-01 |
| Oxaliplatin in Treating Children With Advanced Solid Tumors (NCT00005844) | St. Jude Children's Research Hospital | 2000-04-01 |
| Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy (NCT00004919) | National Cancer Institute (NCI) | 1999-12-01 |
| Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer (NCT00112593) | Fred Hutchinson Cancer Center | 1999-11-01 |